LetermovirLack of efficacy and off-label use : case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2019卷 / 1期

关键词：

D O I：

10.1007/s40278-024-64155-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：242 / 242

相关论文

共 50 条

[1] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1866 (1) : 47 - 47
[2] BevacizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2042 (1) : 81 - 81
[3] AcetylcysteineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1900 (1) : 16 - 16
[4] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1838 (1) : 56 - 56
[5] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 178 - 178
[6] HydroxychloroquineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 264 - 264
[7] AzithromycinLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1878 (1) : 110 - 110
[8] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1943 (1) : 84 - 84
[9] NivolumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 417 - 417
[10] FavipiravirLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 175 - 175

← 1 2 3 4 5 →